Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2023-05-15 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年第1季海外子公司投資
Interim / Quarterly Report Classification · 90% confidence The document is a financial disclosure related to investment holdings and equity method accounting for overseas subsidiaries, showing detailed investment amounts, shareholding percentages, and recognized investment gains or losses for the first quarter of the 112th year (likely a fiscal quarter). The document length is 2485 characters, which is relatively short and contains detailed financial data for a specific quarter. It is not a full annual report but rather a quarterly or interim financial report with substantive financial data. There is no indication that this is an announcement or a certification, but actual financial figures are presented. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-15 Chinese
112年第1季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory approval limits. The content is focused on investment details rather than a full financial report or earnings announcement. The document length is short (1439 characters), but it contains substantive financial data related to investments, not just an announcement or certification. This type of disclosure aligns with regulatory filings related to investment disclosures rather than full annual or interim reports. Given the nature and format, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-05-15 Chinese
112年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first quarter of the fiscal year 112 (2023) and the same period last year. It includes line items such as common stock, capital surplus, retained earnings, and other equity components. The presence of actual financial figures and the quarterly period indicate this is a substantive financial report for a period shorter than a full fiscal year. The document length is 3773 characters, which is under 5000 characters, but the content is detailed financial data, not just an announcement or a link to a report. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the year 112 (Taiwan calendar, corresponding to 2023). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a quarterly period indicates this is a comprehensive interim financial report rather than a brief announcement or certification. The document length is 2709 characters, which is relatively short but contains substantive financial data, so it is not merely a report publication announcement or regulatory filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 112 (Taiwan calendar, corresponding to 2023). It includes detailed financial figures such as revenue, costs, expenses, net profit, and earnings per share for the quarter ending March 31, 2023, compared to the same period in the previous year. The presence of actual financial data and the quarterly period covered indicate this is a financial report for a period shorter than a full fiscal year. The document length is 2263 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated balance sheet data with specific financial figures for multiple dates, including the first quarter of the year 112 (Taiwan calendar, corresponding to 2023). It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, and equity. The presence of actual financial data and detailed accounting items indicates this is a financial report rather than an announcement or summary. The document length is 4395 characters, which is relatively short but contains substantive financial data. Given the quarterly date reference and detailed financial statements, this fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.